NATIONAL CANINE LYMPHOMA AWARENESS DAY | NATIONAL CASH BACK DAY | NATIONAL RETINOL DAY | BITTERSWEET CHOCOLATE WITH ALMONDS ...

Nkarta’s pivot from oncology to autoimmune disease has continued with the biotech halting work on its CD19-directed CAR NK in lymphoma to focus on lupus. Seven patients with heavily pretreated large B ...

The study systematically characterized RILD using bronchoalveolar lavage and high-resolution CT in 321 patients, mostly with ...

An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial.

July 22, 2024 — The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for ...

Christopher R. Flowers, MD, MS, discusses what the current treatment landscape of follicular lymphoma looks like.

Viracta Therapeutics is implementing its second round of layoffs in just three months as the cash-strapped biotech tries to keep funds flowing to its lymphoma program. | Viracta Therapeutics is ...

Treatment for follicular lymphoma is not one-size-fits-all. Many treatments are available for this form of non-Hodgkin's lymphoma. While it may be overwhelming to face so many choices, a wide ...

Stephens initiates coverage on ADC Therapeutics (ADCT), highlighting Zynlonta's potential in second-line DLBCL and a ...

"This latest trial suggests that [nivolumab plus AVD] may become the treatment of choice for all stages of Hodgkin's lymphoma." SWOG S1826 is a phase III, multicenter, randomized trial involving ...

Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, ...